GLP-1 & GIP analogs
Survodutide
- Half-life
- ~6 days
Survodutide is studied as a dual GLP-1/GIP receptor agonist for glucose-regulation and satiety-signalling research.
€100.00VAT incl.
Batch TVL-2605-42 · 99.0%
GDPR by default
ISO/GMP certified production
Batch-level COA on every order
EU warehouse, 2–5 days
Ships from our EU warehouse, 2–5 business days.
Research use only. Not for human or animal consumption. Age and research-use verification required at checkout.